Seaport Therapeutics doses first patient in anxiety trial

🌐 Investing.com (Cyprus) —
Seaport Therapeutics doses first patient in anxiety trial

AI Summary

Seaport Therapeutics has dosed the first participant in a clinical trial for an anxiety treatment. The article does not provide trial details or the treatment's name.

Markets Health Seaport Therapeutics anxiety clinical trial first patient dosed drug development

Read original source →